Skip to main content
Print This Page
Text Size
Scroll To Top
facebook
Member Login
menu
Home
About us
Benefits
Member Signup
2025 Research Symposium
Resources
Contact Us
Home
News / Articles List
Details
News / Articles
FDA approves first generic naloxone nasal spray to treat opioid overdose
Published on 4/23/2019
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm636333.htm
Return to Previous Page